Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.11B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$317M |
| 3 |
Linde
LIN
|
+$290M |
| 4 |
Danaher
DHR
|
+$275M |
| 5 |
Home Depot
HD
|
+$246M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$732M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$731M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$574M |
| 4 |
Meta Platforms (Facebook)
META
|
+$573M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$484M |
Sector Composition
| 1 | Financials | 16.4% |
| 2 | Technology | 14.23% |
| 3 | Healthcare | 12.49% |
| 4 | Industrials | 10.09% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Praxis Precision Medicines
PRAX
$794M
| $2.62M | ﹤0.01% |
69,181
-81,711
| -54% | -$3.09M |
|
2302
Immunovant
IMVT
$2.73B
| $2.62M | ﹤0.01% |
153,240
+6,143
| +4% | +$105K |
|
2303
Enliven Therapeutics
ELVN
$1.16B
| $2.62M | ﹤0.01% |
132,887
+82,083
| +162% | +$1.62M |
|
2304
CVB Financial
CVBF
$2.77B
| $2.62M | ﹤0.01% |
141,669
-34,996
| -20% | -$646K |
|
2305
Tompkins Financial
TMP
$999M
| $2.61M | ﹤0.01% |
41,520
+20,522
| +98% | +$1.29M |
|
2306
IAC Inc
IAC
$2.92B
| $2.61M | ﹤0.01% |
69,277
-234,989
| -77% | -$8.86M |
|
2307
United States Antimony
UAMY
$620M
| $2.61M | ﹤0.01% |
1,186,582
+1,085,789
| +1,077% | +$2.39M |
|
2308
Harmony Biosciences
HRMY
$1.85B
| $2.61M | ﹤0.01% |
78,492
+72,159
| +1,139% | +$2.39M |
|
2309
Theravance Biopharma
TBPH
$703M
| $2.6M | ﹤0.01% |
291,534
+98,695
| +51% | +$881K |
|
2310
Pacific Biosciences
PACB
$348M
| $2.6M | ﹤0.01% |
2,204,044
-14,861,287
| -87% | -$17.5M |
|
2311
SiTime
SITM
$7.17B
| $2.6M | ﹤0.01% |
17,005
+9,661
| +132% | +$1.48M |
|
2312
LifeMD
LFMD
$278M
| $2.59M | ﹤0.01% |
476,462
-409,525
| -46% | -$2.23M |
|
2313
Omeros
OMER
$279M
| $2.59M | ﹤0.01% |
315,252
+229,581
| +268% | +$1.89M |
|
2314
Lakeland Industries
LAKE
$140M
| $2.59M | ﹤0.01% |
127,465
+99,682
| +359% | +$2.02M |
|
2315
Inspire Medical Systems
INSP
$2.4B
| $2.59M | ﹤0.01% |
16,246
+11,195
| +222% | +$1.78M |
|
2316
Quest Diagnostics
DGX
$20.3B
| $2.58M | ﹤0.01% |
15,276
-638,498
| -98% | -$108M |
|
2317
Realty Income
O
$55.4B
| $2.58M | ﹤0.01% |
44,433
-1,262,556
| -97% | -$73.2M |
|
|
PCSC
2318
Perceptive Capital Solutions Corp Class A Ordinary Shares
PCSC
| $2.58M | ﹤0.01% |
250,000
| – | – |
|
2319
Hawthorn Bancshares
HWBK
$222M
| $2.57M | ﹤0.01% |
91,050
+65,169
| +252% | +$1.84M |
|
2320
RLI Corp
RLI
$6.13B
| $2.57M | ﹤0.01% |
31,988
-24,004
| -43% | -$1.93M |
|
2321
General Mills
GIS
$26.6B
| $2.56M | ﹤0.01% |
42,865
-255,423
| -86% | -$15.3M |
|
2322
Fulton Financial
FULT
$3.51B
| $2.56M | ﹤0.01% |
141,665
-1,337,070
| -90% | -$24.2M |
|
2323
iShares US Aerospace & Defense ETF
ITA
$9.39B
| $2.56M | ﹤0.01% |
+16,733
| New | +$2.56M |
|
2324
Groupon
GRPN
$926M
| $2.56M | ﹤0.01% |
+136,451
| New | +$2.56M |
|
|
CCIR
2325
DELISTED
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
| $2.56M | ﹤0.01% |
+228,348
| New | +$2.56M |
|